Gastritis pp 177-182 | Cite as


  • Rodolfo Cheli
  • Alessandro Perasso
  • Attilio Giacosa


The therapeutic approach toward chronic gastritis poses numerous problems.


Gastric Mucosa Iron Deficiency Anemia Chronic Gastritis Ursodeoxycholic Acid Pernicious Anemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Allen A, Garner A (1980) Mucus and bicarbonate secretion in the stomach and their role in mucosal protection. Gut 21:249–262PubMedCrossRefGoogle Scholar
  2. Baldini M, Cheli R (1957) Le alterazioni anatomiche e funzionali dello stomaco negli anemici. Minerva Med 48:322Google Scholar
  3. Berstad A (1972) Inhibition of peptic activity in man by carbenoxalone sodium. Scand J Gastroenterol 7:129PubMedGoogle Scholar
  4. Buch KL, Weinstein WM, Hill TA, Elashoff JD, Reedy TJ, Ippoliti AF, Tedesco FJ, Singh M (1985) Sucralfate therapy in patients with symptoms of alkaline reflux gastritis. Am J Med 79 [Suppl 2e]:49–54PubMedCrossRefGoogle Scholar
  5. Camarri E, Zaccherotti L, D’Alonzo D (1972) Study of the concentration of mucoprotein in the gastric juice from healthy subjects and gastroduodenal patients before and after treatment with a gastroprotective drug, zolimidine. Arzneimittelforsch (Drug Res) 22:768Google Scholar
  6. Caspary WF, Graf S (1981) Binding of bile acids by sucralfate and cholestyramine. In: Caspary WF (ed) Sucralfate. A new therapeutic concept. Urban and Schwarzenberg, MünchenGoogle Scholar
  7. Cheli R, Giacosa A (1983) Medical treatment of chronic gastritis and chronic duodenitis. In: Dobrilla G, Liguory C, Misiewicz G (eds) Current therapy of gastrointestinal disorders. Cortina International-Raven, VeronaGoogle Scholar
  8. Domschke W, Domschke S, Classen H, Demling L (1972) N-Acetylneuraminic acid in gastric mucus. A possible mediator of carbenoxolone action in gastric ulcer patients. Acta Hepatogastroenterol 19:204Google Scholar
  9. Domschke W, Domschke S, Magel J, Demling L, Cruft DN (1977) Gastric epithelial cell turnover, mucus production and healing of gastric ulcers with carbenoxalone. Gut 18:817PubMedCrossRefGoogle Scholar
  10. Giacosa A, Molinari F, Perasso A (1978) Valutazione comparativa nel trattamento dell’ulcera gastrica con carbenoxalone, xilamide e zolimidina. Sett Med 66:429–433Google Scholar
  11. Goldstein H, Murphy D, Sokol A, Rubini ME (1976) Gastric acid secretion in patients undergoing chronic dialysis. Arch Intern Med 120:645–653CrossRefGoogle Scholar
  12. Harmon JW, Doong T, Gadacz TR (1978) Bile acids are not equally damaging to the gastric mucosa. Surgery 84:79–86PubMedGoogle Scholar
  13. Ikkala E, Salmi HJ, Siurala M (1970) Gastric mucosa in iron deficiency anemia. Results of follow-up examination. Acta Haematol 43:228PubMedCrossRefGoogle Scholar
  14. Jeffries GH, Todd JE, Sleisenger MA (1966) The effect of prednisolone on gastric mucosal histology, gastric secretion and vitamin B12 absorption in patients with pernicious anemia. J Clin Invest 45:803PubMedCrossRefGoogle Scholar
  15. Joske RA, Finckh EF, Wood IJ (1955) Gastric biopsy. A study of 1000 consecutive successful gastric biopsies. Q J Med 24:269PubMedGoogle Scholar
  16. Konturek SJ (1981) Role of prostaglandins in gastric cytoprotection. In: Domschke W, Wormsley KG (eds) Magen und Magenkrankheiten. Thieme, StuttgartGoogle Scholar
  17. Konturek SJ (1984) Gastric cytoprotection. Abstract: XII International Gastroenterology Congress — V European Gastrointest. Endoscopy Congress. 16–22 Sept 1984, LisbonGoogle Scholar
  18. Konturek SJ, Kniecen N, Swierczer J, Olesry J, Sito E, Robert A (1976) Comparison of methylated prostaglandin E2 analogues given orally in the inhibition of gastric responses to pentagastrin and peptone meal in man. Gastroenterology 70:633Google Scholar
  19. Konturek SJ, Brzozowski T, Radeki T, Piastucki I (1982) Gastric cytoprotection by piren-zepine. Role of endogenous prostaglandins. Scand J Gastroenterol 17 (suppl 72):255–259Google Scholar
  20. Konturek SJ, Radeki T, Piastucki I, Drozdowicz D (1986) Meccanismi citoprotettivi del DeNol. Recenti esperienze. In: Bianchi-Porro G, Baroni S, Parenti F (eds) De-Nol, un nuovo concetto di citoprotezione. Libreria Cortina, VeronaGoogle Scholar
  21. Lambert JR, Hansky J, Eaves ER, Korman MG, Pinkard K, Medley G (1985) Campylobacter-like organisms (CLO) in human stomach. Gastroenterology 88:1463Google Scholar
  22. Marshall BJ, Warren JR (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311–1314PubMedCrossRefGoogle Scholar
  23. Robert A (1975) Antisecretory, antiulcer, cytoprotective and diarrheogenic properties of prostaglandins. In: Samuelsson B, Paoletti R (eds) Advances in prostaglandin and thromboxane research. Raven, New YorkGoogle Scholar
  24. Robert A (1979) Cytoprotection by prostaglandins. Gastroenterology 77:761–767PubMedGoogle Scholar
  25. Rollason TP (1986). Campylobacter-like organisms in the human stomach. A Review. Acta Gastro-ent Belg 49:63–69Google Scholar
  26. Stefaniwsky AB, Tint GS, Speck J, Shefer S, Salen G (1985) Ursodeoxycholic acid treatment of bile reflux gastritis. Gastroenterology 89:1000–1004PubMedGoogle Scholar
  27. Tytgat GNJ, Rauws E, Langenberg W (1986) Il ruolo del De-Nol nell’ulcera gastrica e nelle gastriti. In: Bianchi-Porro G, Baroni S, Parenti F (eds) De-Nol, un nuovo concetto di citoprotezione. Libreria Cortina, VeronaGoogle Scholar
  28. Wood IJ, Taft LI (1958) Diffuse lesions of the stomach. Arnold, LondonGoogle Scholar
  29. McConnel JB, Stewart WK, Thyodleifsson D, Wormsley KG (1975) Gastric function in chronic renal failure. Effects of maintenance haemodialysis. Lancet 1:1121–1123CrossRefGoogle Scholar
  30. Milito G, Taccone M, Brancaleone C, Nardi F, Filingeri V, Cesca D, Casciani CU (1983) A comparative study of the stomach and duodenum in dialysis and renal transplant patients. Ital J Gastroenterol 15:17–22Google Scholar
  31. Parodi MC, Molinari F (1983) Comportamento della secrezione mucosa gastrica dopo sornministrazione in bolo rapido di cimetidina e pirenzepina. Il Gastroenterologo 3:104–105Google Scholar
  32. Parodi MC, Molinari F, Cheli R (1984). Effetti della ranitidina somministrata in bolo rapido sulla secrezione mucosa gastrica. In: Barbara L, Dobrilla G (eds) Problemi di gastroen-terologia e ranitidina. Cortina, VeronaGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • Rodolfo Cheli
    • 1
  • Alessandro Perasso
    • 1
  • Attilio Giacosa
    • 2
  1. 1.S. Martino HospitalGenovaItaly
  2. 2.National Institute for Cancer ResearchGenovaItaly

Personalised recommendations